Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Expert answers to our most frequently asked questions Tirzepatide is a dual GIP/GLP-1 receptor agonist that simultaneously targets two key hormones
GLP-1 is glucagon-like peptide one, and this is a hormone that is produced by our intestinal cells
Boosts skin elasticity and supports hair growth
Vitamin D is known to contribute to muscle and bone health [56]
The titration regimen described in the NEJM 2023 obesity trial (Jastreboff et al.) progressed as follows: Weeks 14 : 2 mg once weekly Weeks 58 : 4 mg once weekly Weeks 912 : 8 mg once weekly Week 12 onwards : Up to 12 mg once weekly (in higher-dose cohorts) This regimen was used exclusively within a regulated clinical trial setting and does not constitute an approved dosing schedule
Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis
US$ 20.52
US$ 28.75
US$ 29.73
US$ 21.64
US$ 26.86
